News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
171,920 Results
Type
Article (16718)
Company Profile (20)
Press Release (155182)
Section
Business (51729)
Career Advice (371)
Deals (8582)
Drug Delivery (46)
Drug Development (30485)
Employer Resources (38)
FDA (4692)
Job Trends (4542)
News (93519)
Policy (8375)
Tag
Academia (1021)
Alliances (12517)
Alzheimer's disease (894)
Antibody-drug conjugate (ADC) (44)
Approvals (4658)
Artificial intelligence (51)
Bankruptcy (55)
Best Places to Work (3688)
Breast cancer (111)
Cancer (708)
Cardiovascular disease (52)
Career advice (316)
CAR-T (61)
Cell therapy (137)
Clinical research (24244)
Collaboration (183)
COVID-19 (1341)
C-suite (48)
Data (669)
Diabetes (78)
Diagnostics (2787)
Drug pricing (42)
Earnings (20134)
Employer resources (38)
Events (19712)
Executive appointments (171)
FDA (4954)
Funding (172)
Gene editing (39)
Gene therapy (96)
GLP-1 (302)
Government (1470)
Healthcare (5268)
Infectious disease (1387)
Inflammatory bowel disease (41)
Interviews (79)
IPO (4179)
Job creations (1041)
Job search strategy (255)
Layoffs (207)
Legal (1426)
Lung cancer (108)
Lymphoma (56)
Manufacturing (83)
Medical device (3167)
Medtech (3169)
Mergers & acquisitions (4470)
Metabolic disorders (232)
Neuroscience (1049)
NextGen Class of 2024 (1602)
Non-profit (1375)
Northern California (633)
Obesity (145)
Opinion (114)
Parkinson's disease (44)
Patents (40)
People (15584)
Phase I (7607)
Phase II (10863)
Phase III (8584)
Pipeline (269)
Postmarket research (709)
Preclinical (2564)
Radiopharmaceuticals (99)
Rare diseases (102)
Real estate (1401)
Regulatory (6027)
Research institute (972)
Resumes & cover letters (42)
Southern California (477)
Startups (1458)
United States (4835)
Vaccines (295)
Weight loss (115)
Date
Today (2)
Last 7 days (74)
Last 30 days (807)
Last 365 days (11895)
2024 (11878)
2023 (13196)
2022 (16113)
2021 (16894)
2020 (15866)
2019 (12181)
2018 (9472)
2017 (9517)
2016 (8515)
2015 (9587)
2014 (6452)
2013 (4774)
2012 (5213)
2011 (5505)
2010 (4806)
Location
Africa (213)
Asia (10823)
Australia (2179)
California (1302)
Canada (427)
China (128)
Colorado (57)
Connecticut (48)
Europe (26412)
Florida (148)
Illinois (110)
Indiana (71)
Maryland (149)
Massachusetts (995)
Michigan (42)
Minnesota (40)
New Jersey (411)
New York (426)
North Carolina (158)
Northern California (633)
Pennsylvania (274)
South America (241)
Southern California (477)
Texas (231)
Utah (43)
Washington State (140)
171,920 Results for "earli".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Partnered
The Strategic Imperative: Why Early Potency Assay Development Makes or Breaks ATMP Success
Not developing potency assays and gaining knowledge about MOAs early in the drug development process not only can break ATMP success but can cause costs and delays that lead to company closures.
December 9, 2024
·
7 min read
·
BioSpace Insights
Obesity
AstraZeneca Bolsters Obesity Pipeline With Promising Early Data for Candidates
While expected and seen as largely incremental, Jefferies analyst Peter Welford in a Tuesday note to investors said the detailed data for three early-stage assets support moving them into Phase IIb studies and creates a “foothold” for AstraZeneca in the weight loss space.
November 5, 2024
·
3 min read
·
Tristan Manalac
Press Releases
“LEQEMBI®" (Lecanemab) Approved for the Treatment of Early Alzheimer’s Disease in Mexico
December 4, 2024
·
9 min read
Cardiovascular disease
Tenaya Stock Crashes as Cardio Gene Therapy Delivers Underwhelming Early-Stage Data
Tenaya’s share slump following the TN-201 data drop could be due to its “significantly lower” level of RNA expression in the Phase Ib/II trial than in preclinical models, according to William Blair analysts.
December 18, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Lilly’s Kisunla™ (donanemab-azbt) Approved in China for the Treatment of Early Symptomatic Alzheimer’s Disease
December 18, 2024
·
14 min read
Press Releases
Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection
December 19, 2024
·
4 min read
Press Releases
Altasciences Supports Metsera in Their Early-Stage Clinical Trials for Obesity
November 21, 2024
·
2 min read
Press Releases
EmStop™ Announces Completion of CAPTURE-1 Early Feasibility Clinical Trial
November 21, 2024
·
2 min read
Press Releases
KFSHRC & Lilly Collaborate in Alzheimer’s Early Detection
November 4, 2024
·
2 min read
Early-Stage Biotechs Now Tying CEO Pay Packages to Capital Raises
As funding dipped, early-stage biotechs began tying CEO package components, including salary increases and equity topoffs, to raising capital.
May 29, 2024
·
4 min read
·
Angela Gabriel
1 of 17,192
Next
